Efficacy and safety of three ciclesonide doses vs placebo in children with asthma: The rainbow study

Respiratory Medicine

Volumn 104, Issue 11, 2010, Pages 1618-1628

  Pedersen, Søren ^a   Potter, Paul ^b   Dachev, Svetoslav ^c   Bosheva, Miroslava ^d   Kaczmarek, Jadwiga ^e   Springer, Ewa ^f   Dunkel, Jochen ^g   Engelstätter, Renate ^g  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c District Hospital for Pulmonary Diseases   (Bulgaria)

^d MEDICAL UNIVERSITY OF PLOVDIV   (Bulgaria)

^e Barlicki University Hospital ^*  (Poland)

^f Alergologia Plus   (Poland)

^g Nycomed GmbH   (Germany)

Author keywords

Asthma control; Inhaled corticosteroid; Paediatric asthma; Pulmonary function; Randomised controlled trial; Spacer device

Indexed keywords

CICLESONIDE; HYDROCORTISONE; PLACEBO;

ARTICLE; ASTHMA; BODY HEIGHT; BRONCHITIS; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EVENING DOSAGE; EXPIRATORY RESERVE VOLUME; FEMALE; FEVER; FORCED EXPIRATORY VOLUME; HUMAN; INHALATION SPACER; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MALE; METERED DOSE INHALER; MULTICENTER STUDY; PEAK EXPIRATORY FLOW; PHARYNGITIS; PRESCHOOL CHILD; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RHINITIS; RISK ASSESSMENT; SCHOOL CHILD; SINUSITIS; SYMPTOMATOLOGY; UPPER RESPIRATORY TRACT INFECTION; URINARY EXCRETION; WHEEZING;

ADMINISTRATION, INHALATION; ANTI-INFLAMMATORY AGENTS; ASTHMA; BODY HEIGHT; CHILD; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYDROCORTISONE; MALE; METERED DOSE INHALERS; PREGNENEDIONES; RESPIRATORY FUNCTION TESTS; TREATMENT OUTCOME;

EID: 77957151226     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2010.06.012     Document Type: Article

References (36)

1. B.E. Chipps Asthma in infants and children Clin Cornerstone 8 2008 44 61
2. Global Initiative for Asthma (GINA) GINA Report, Global Strategy for Asthma Management and Prevention (2008 update) Available from: www.ginasthma.com/Guidelineitem.asp?l1=2&;12=1&intId=60 [accessed 14.01.09]
3. National Heart LaBINational Asthma Education and Prevention Program Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma Full Report 2007 Available from: http://www.nhlbi.nih.gov/guidelines/asthma/ asthgdln.pdf
4. G. Rachelefsky Inhaled corticosteroids and asthma control in children: assessing impairment and risk Pediatrics 123 2009 353 366
5. S. Pedersen Do inhaled corticosteroids inhibit growth in children? Am J Respir Crit Care Med 164 2001 521 535
6. GAPP Working Group Global Asthma Physician and Patient (GAPP) Survey:Global Adult Highlights Available from: http://www.gappsurvey.org/ healthcare-contact.html
7. M. Stoeck, R. Riedel, G. Hochhaus, D. Häfner, J.M. Masso, and B. Schmidt In vitro and in vivo anti-inflammatory activity of the new glucocorticoid ciclesonide J Pharmacol Exp Ther 309 2004 249 258
8. E.W. Gelfand, J.W. Georgitis, M. Noonan, and M.E. Ruff Once-daily ciclesonide in children: efficacy and safety in asthma J Pediatr 148 2006 377 383
9. A. Von Berg, R. Engelstätter, P. Minic, M. Sréckovic, M.L. Garcia Garcia, and T. Latos Comparison of the efficacy and safety of ciclesonide 160 μg once daily vs. budesonide 400 μg once daily in children with asthma Pediatr Allergy Immunol 18 2007 391 400
10. S. Pedersen, M.L. Garcia Garcia, A. Manjra, I. Theron, and R. Engelstätter A comparative study of inhaled ciclesonide 160 μg/day and fluticasone propionate 176 μg/day in children with asthma Pediatr Pulmonol 41 2006 954 961
11. S. Pedersen, R. Engelstätter, H.-J. Weber, S. Hirsch, L. Barkai, and A. Emeryk Efficacy and safety of ciclesonide once daily and fluticasone propionate twice daily in children with asthma Pulm Pharmacol Ther 22 2009 214 220
12. K. Phillips, J. Oborne, S. Lewis, T.W. Harrison, and A.E. Tattersfield Time course of action of two inhaled corticosteroids, fluticasone propionate and budesonide Thorax 59 2004 26 30
13. Global Initiative for Asthma (GINA) GINA Report, Global Strategy for Asthma Management and Prevention (2004 update) Natl Heart Lung Blood Inst 2004 NIH Publication 02.3659
14. M.R. Miller, R. Crapo, J. Hankinson, V. Brusasco, F. Burgos, and R. Casaburi General considerations for lung function testing Eur Respir J 26 2005 153 161
15. M.R. Miller, J. Hankinson, V. Brusasco, F. Burgos, R. Casaburi, and A. Coates Standardisation of spirometry Eur Respir J 26 2005 319 338
16. G. Polgar, and V. Promadhat Pulmonary function testing in children: techniques and standards 1971 W.B. Saunders Philadelphia, USA p. 170-180
17. E.F. Juniper, G.H. Guyatt, D.H. Feeny, P.J. Ferrie, L.E. Griffith, and M. Townsend Measuring quality of life in children with asthma Qual Life Res 5 1996 35 46
18. J. Price, P. Hindmarsh, S. Hughes, and J. Efthimiou Evaluating the effects of asthma therapy on childhood growth: what can be learnt from the published literature? Eur Respir J 19 2002 1179 1193
19. H.K. Reddel, D.R. Taylor, E.D. Bateman, L.P. Boulet, H.A. Boushey, and W.W. Busse An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice Am J Respir Crit Care Med 180 2009 59 99
20. S.T. Holgate, J. Bousquet, K.F. Chung, H. Bisgaard, R. Pauwels, and L. Fabbri Summary of recommendations for the design of clinical trials and the registration of drugs used in the treatment of asthma Respir Med 98 2004 479 487
21. B. Thorsteinsdottir, G.W. Volcheck, M.B. Enemark, A.M. Patel, J.T. Li, and K.G. Lim The ABCs of asthma control Mayo Clin Proc 83 2008 814 820
22. N.C. Santanello, J. Zhang, B. Seidenberg, T.F. Reiss, and B.L. Barber What are minimal important changes for asthma measures in a clinical trial? Eur Respir J 14 1999 23 27
23. M.E. Kemeny, L.J. Rosenwasser, R.A. Panettieri, R.M. Rose, S.M. Berg-Smith, and J.N. Kline Placebo response in asthma: a robust and objective phenomenon J Allergy Clin Immunol 119 2007 1375 1381
24. D.P. Joyce, C. Jackevicius, K.R. Chapman, R.A. McIvor, and S. Kesten The placebo effect in asthma drug therapy trials: a meta-analysis J Asthma 37 2000 303 318
25. A.L. Boner, G. Vallone, D.G. Peroni, G.L. Piacentini, and D. Gaburro Efficacy and duration of action of placebo responses in the prevention of exercise-induced asthma in children J Asthma 25 1988 1 5
26. R.A. Wise, S.J. Bartlett, E.D. Brown, M. Castro, R. Cohen, and J.T. Holbrook Randomized trial of the effect of drug presentation on asthma outcomes: the American Lung Association Asthma Clinical Research Centers J Allergy Clin Immunol 124 2009 436 438
27. D.B. Peden, W.E. Berger, M.J. Noonan, M.R. Thomas, V.L. Hendricks, and A.G. Hamedani Inhaled fluticasone propionate delivered by means of two different multidose powder inhalers is effective and safe in a large pediatric population with persistent asthma J Allergy Clin Immunol 102 1998 32 38
28. A. Nayak, R. Lanier, S. Weinstein, P. Stampone, and M. Welch Efficacy and safety of beclomethasone dipropionate extrafine aerosol in childhood asthma: a 12-week, randomized, double-blind, placebo-controlled study Chest 122 2002 1956 1965
29. W.E. Berger, H. Milgrom, P. Chervinsky, M. Noonan, S.F. Weinstein, and B.N. Lutsky Effects of treatment with mometasone furoate dry powder inhaler in children with persistent asthma Ann Allergy Asthma Immunol 97 2006 672 680
30. J. Maspero, F. Guerra, F. Cuevas, J.P. Gutierrez, M. Soto-Ramos, and S. Anderton Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: a prospective, randomized, double-blind, double-dummy, parallel-group study Clin Ther 30 2008 1492 1504
31. L. Agertoft, and S. Pedersen Lower-leg growth rates in children with asthma during treatment with ciclesonide and fluticasone propionate Pediatr Allergy Immunol 21 2010 e199 205
32. E.O. Meltzer, J.L. Sotomayor, S. Kundu, and D. Banerji Long-term safety profile of once-daily ciclesonide in children with persistent asthma of all severities Ann Allergy Asthma Immunol 96 2006 140
33. D.P. Skoner, J. Maspero, D. Banerji Ciclesonide Pediatric Growth Study Group Assessment of the long-term safety of inhaled ciclesonide on growth in children with asthma Pediatrics 121 2008 e1 e14
34. K.R. Chapman Safer inhaled corticosteroid therapy for asthma Pediatrics 121 2008 179 180
35. B. Kassai, M. Cucherat, and G. Bellon Ciclesonide noninferiority to placebo on growth velocity Pediatrics 122 2008 676 677
36. S. Malozowski Assessment of the long-term safety of inhaled ciclesonide on growth in children with asthma Pediatrics 122 2008 213